Annual Report for Fiscal Year Ending June 30, 2024 (Form 10-K)
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq[...]
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat[...]
06/29/2022 | Press release | Distributed by Public on 06/29/2022 01:27
Please select the service you want to use:
Smartlinks | Shin-Etsu Chemical Co. Ltd. | Company News | Shareholders | Shareholder Meeting | Public Companies | Commodity Chemicals Companies | Börse Frankfurt | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Nagoya Stock Exchange (NSE) | OTC Markets | Tokyo Stock Exchange (TSE) | Chi-X Japan | SBI Japannext
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact